Monopar Announces New Drug Candidate and Collaborates with the National University of Singapore for Preclinical Evaluation in Cancer Development of novel
Camsirubicin analogue expands Monopar’s therapeutic pipeline. Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company primarily focused on developing proprietary therapeutics designed...